Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M
Eli Lilly will partner Oxford-based Sitryx to develop up to four drug candidates to treat…
03/04/2020 - 2 minutes
Eli Lilly
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
24/03/2020 - 3 minutes
Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…
30/09/2019 - 4 minutes
AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…
23/09/2019 - 2 minutes
Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics
In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1…
06/09/2018 - 2 minutes
Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
23/02/2018 - 3 minutes
Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval
Update (13/02/2018): The European Commission has given Novo Nordisk a market authorization for Ozempic (semaglutide), bringing…
13/02/2018 - 2 minutes
Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines
CureVac will be working with pharma giant Eli Lilly in the development of up to…
18/10/2017 - 3 minutes
Eli Lilly Partners with German Biotech Against Autoimmune Disease
Topas Therapeutics has signed a multi-year agreement with Eli Lilly to develop drug candidates for…
22/08/2017 - 2 minutes
Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s
Novo Nordisk has reported Phase III data that reveal its candidate semaglutide improved glucose control…
18/08/2017 - 1 minute
German Biotech Unveils Positive Phase II Results for Alzheimer’s
Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead…
12/06/2017 - 3 minutes
Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin
Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone…
27/01/2017 - 2 minutes
